You searched for metabolic diseases - Page 36 of 64

News and Trends 6 Dec 2023

A gene editing milestone: The FDA approves CASGEVY, the first CRISPR-based therapy

Still a relatively new technology, CRISPR has been heralded in recent years as having the potential to tackle a range of diseases. And now, it has finally proved its worth….

December 6, 2023 - 6 minutesmins - By Willow Shah-Neville

News and Trends 4 Oct 2022

Spinoff Biohaven launches with $258M and “incredible pipeline”

Biohaven Ltd. launched today as a new publicly traded company focused on delivering innovative life-changing treatments for neurological and neuropsychiatric diseases, including rare disorders. As of today, Biohaven has officially…

October 4, 2022 - 4 minutesmins - By Jim Cornall

Opinion 11 Jul 2023

Unlocking the power of mRNA technology

…are used to train the immune system against specific viruses without exposing the body to live pathogens. This breakthrough approach has provided a foundation for combating infectious diseases. Another significant…

July 11, 2023 - 4 minutesmins - By External Contributor

Interview 21 Apr 2021

Changing Attitudes on Vaccine and Public Health Investment

…predominantly defined as high-burden and neglected infectious diseases,” he explained. “Not being very creative as bankers, we said, ‘why don’t you sponsor the creation of an investment fund and demonstrate…

April 21, 2021 - 5 minutesmins - By Helen Albert

organoids in a dish, drug development, patient relevant model

The organoid era: bringing patient-relevant preclinical models to the lab

…of human diseases, noted Federica Parisi, Marketing and Sales Manager at HUB Organoids. “We have used organoids to study diseases beyond oncology — such as cystic fibrosis or irritable bowel…

July 12, 2022 - 7 minutesmins - By Sudha Sundaram

News and Trends 28 Nov 2022

Licensing agreement signed for C4XD between C4X Discovery and AstraZeneca

…therapy, C4XD. This is for the treatment of inflammatory and respiratory diseases with a lead focus on chronic obstructive pulmonary disease (COPD). C4X Discovery will receive pre-clinical milestone payments worth up…

November 28, 2022 - 3 minutesmins - By Liza Laws

News and Trends 19 Dec 2017

Giving Molecular Combing the Golden Coat It Deserves

…of different diseases. A golden coat for a long-lasting effect Molecular combing of DNA can be used for the analysis of genome variations, as well as gene editing, cancer diagnosis…

December 19, 2017 - 5 minutesmins - By External Contributor

More News! 4 Jan 2018

Belgian Biotech Hits ‘Fast Forward’ on Multiple Sclerosis Therapies

…multiple sclerosis and other myelin-related diseases. Rewind will use the money to move its first small molecule product to the clinic and to expand its pipeline. Multiple sclerosis is caused…

January 4, 2018 - 2 minutesmins - By Alex Dale

News and Trends 8 Jan 2020

Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment

…diseases in the future. “Rare diseases remain an area of significant unmet medical need, where our team’s proven track record and entrepreneurial mindset will enable us to have a positive…

January 8, 2020 - 2 minutesmins - By Helen Albert

News and Trends 15 May 2017

German Biotech Clears Phase I with New Gene Therapy for Glaucoma

…(DME). “We are now moving towards Phase II development in advanced glaucoma but also other TGF-β2 associated diseases such as wet Age-related Macular Degeneration (AMD) and other TGFβ2-associated diseases such…

May 15, 2017 - 2 minutesmins - By Melanie De Almeida

lupus autoimmune disease neutrophil citryll

News and Trends 26 Oct 2022

Partnership for better understanding of Sjögren’s syndrome announced by Evotec

…expand Evotec’s E.MPD database into autoimmune diseases. The conventional symptomatic description of many diseases stands in the way of both diagnosis and effective treatment. “By leveraging PanOmics data, we are…

October 26, 2022 - 3 minutesmins - By Liza Laws

News and Trends 15 Jan 2018

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

…blood-brain barrier. Neurodegenerative diseases are a hot topic, with age-related diseases like Alzheimer’s and Parkinson’s rising in prevalence. In the US alone, 5 million people suffer from Alzheimer’s disease, 1…

January 15, 2018 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

A gene editing milestone: The FDA approves CASGEVY, the first CRISPR-based therapy

Spinoff Biohaven launches with $258M and “incredible pipeline”

Unlocking the power of mRNA technology

Changing Attitudes on Vaccine and Public Health Investment

The organoid era: bringing patient-relevant preclinical models to the lab

Licensing agreement signed for C4XD between C4X Discovery and AstraZeneca

Giving Molecular Combing the Golden Coat It Deserves

Belgian Biotech Hits ‘Fast Forward’ on Multiple Sclerosis Therapies

Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment

German Biotech Clears Phase I with New Gene Therapy for Glaucoma

Partnership for better understanding of Sjögren’s syndrome announced by Evotec

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!